Innovation  -  Excellence  - ​ Caring

​Immunology and cell based assay development 

contract research services

Immunity Diagnostics Inc. is a contract research organization (CRO) that specializes in immunology and cell based assay research and development.  From processing of blood, bone marrow, and tissue samples to isolation and analysis of immune populations from these sources, Immunity Diagnostics can develop and validate GLP-compliant SOP to support the needs of pre-clinical and clinical research projects.  

Immunotherapy has demonstrated the potential to treat human disease by stimulating adequate and robust immune responses against cancers and pathogens, and reigning in uncontrolled autoimmunity that leads to chronic and debilitating conditions.  Nonetheless, the immune system is extremely complex, composed of a large variety of cells that produce chemical signals in response to a wide variety of stimuli, and are fine-tuned to autoregulate and self-limit these reactions. Indeed, every immune cell type has plasticity and can be inflammatory, anti-inflammatory, and likely many stages in between. 

If your company is developing novel immunotherapy strategies and looking to partner with a CRO that prioritizes

• Scientific quality and excellence accompanied by industry standard GLP-compliant reporting
• Specialized expertise in cell based assay services
• Personalized, client-focused strategic partnership to achieve specific goals within budget and timelines

Immunity Diagnostics will provide you GLP compliant quality cell based assay services.

EARLY DISCOVERY

• Clinical and scientific diligence on potential targets
• Design and preparation of target validation experiments
• Design and preparation of experimental protocols
• Strategic selection of IN VITRO & IN VIVO Go/No-go decision
• CRO selection and oversight support
• Strategic development of target product profile (TPP)
• Provide support and recommendations on external collaborations
• Support grant preparation and other funding activities
• Provide support and recommendations on external collaborations
• Support grant preparation and other funding activities

PRE-CLINICAL

• Design and Preparation of IND enabling experimental plan
• Design and preparation of GLP- compliant study protocols
• Nonclinical program review and strategic support for FDA submissions
• Nonclinical CRO selection and oversight support
• Provide support and recommendations on external collaborations

CLINICAL

• Clinical CRO selection and oversight support
• Support in engaging clinical, CMC, pharmacology & toxicology, and regulatory KOL

Immunity Diagnostics Inc.
888 West 8th Avenue #310
Vancouver, BC V5Z 3Y1
info@immunity-dx.com
​